Back to Newsroom
Back to Newsroom

FibroGen INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In FibroGen, Inc. To Contact The Firm

Wednesday, 15 May 2019 01:00 PM

Faruqi & Faruqi, LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / May 15, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN).

If you invested in FibroGen stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/FGEN. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].

CONTACT:

FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017

Attn: Richard Gonnello, Esq.
[email protected]

Telephone: (877) 247-4292 or (212) 983-9330

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: